It is not but distinct how to take care of likely FDA approval of psychedelics in the context of ongoing DEA Schedule I classification.twenty Also, it can be unclear how the healthcare method would carry out copyright therapy, which can be a spectacular departure from now available health care and behavioral therapies and raises unique troubles.21T